Cell Biosciences inks deal for Alpha Innotech

Cell Biosciences is buying Alpha Innotech for $1.50 per share, or about $17.9 million in cash. The acquisition expands Cell Biosciences' protein analysis business. "This strategic acquisition marks an important milestone in our plan to create a profitable, high-growth protein analysis business with global reach. There is a great strategic fit in people, products, technologies, and customers between Cell Biosciences and Alpha Innotech. I am particularly excited by the critical mass of talent and industry experience this combination creates." Release